LECO?s TruTOF? GC-TOFMS is a cost-competitive, Time of Flight Mass Spectrometry (TOFMS) instrument in a benchtop design.
LECO’s TruTOF™ GC-TOFMS is a cost-competitive, Time of Flight Mass Spectrometry (TOFMS) instrument in a benchtop design. The TruTOF has both electron impact (EI) and chemical ionisation (CI) ‘plug-and-play’ ion source options for optimal flexibility in the laboratory. Choosing TruTOF GC-TOFMS offers speed of analysis and fully automated data processing by taking advantage of the LECO ChromaTOF single software platform with True Signal Deconvolution® (TSD®).
Data acquisition and data processing efficiency is achieved using data acquisition rates of up to 80 spectra/second across the full mass range (5 to 1000 u) combined with data deconvolution. Reliable mass spectral deconvolution & peak assignment relies on the spectral continuity across the chromatographic peak and is the reason the LECO TOFMS is the detector of choice.
LECO’s ChromaTOF software package is world regarded for its flexibility and logical ease of use. Using a single software platform for a fully automated data acquisition and data processing solution also provides the operator with continuity and an organised, easy to handle workspace.
LECO’s TruTOF GC-TOFMS gives you more information with less sampling time and saves precious people time.
Visit ref="http://www.leco.com">www.leco.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.